Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2025-12-26 @ 2:40 PM
Study NCT ID:
NCT01000506
Status:
COMPLETED
Last Update Posted:
2018-01-24
First Post:
2009-10-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-11-01
Start Date Type:
None
Primary Completion Date:
2012-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03-23
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-22
First Submit QC Date:
None
Study First Post Date:
2009-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-09
Results First Submit QC Date:
None
Results First Post Date:
2016-02-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-11-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-01-18
Last Update Post Date:
2018-01-24
Last Update Post Date Type:
ACTUAL